| Literature DB >> 34635755 |
Maduka Donatus Ughasoro1, James Onuorah Akpeh2, Nneamaka Echendu3, Nneka Gertrude Mgbachi4, Somkene Okpala3, Linda Amah3, Onyinye Henrietta Okolo5, Ngozika Udem6.
Abstract
Acute tonsillitis remains one of the common childhood diseases in developing countries. Prompt and appropriate treatment based on the knowledge of the causative microbiota and their antimicrobial susceptibility pattern will improve the treatment outcome and reduce time and resources spent on treatment. This study aims to determine the pattern of microbiota isolates and their susceptibility pattern. The study was a combination of the retrospective and cross-sectional method. The medical records of children treated for tonsillitis were retrieved, as well as those of children who presented with acute tonsillitis for the study. Interviewer-administered questionnaire was used to collect data, as well as document information retrieved from their medical record: presenting symptoms, treatments received. Swab sample was taken for culture and antibiotic susceptibility test. Out of the 72 swab cultures, 29 (40.3%) yielded insignificant growth of gram positive cocci. A total of nine (9) different isolates were obtained from all the significant swab cultures. Streptococcus species (13, 18.6%) and staphylococcus species (11, 15.3%) were the commonest isolates. Imipenem and levofloxacin revealed high level of susceptibility, while Ampicillin and Cefexine recorded high resistance rates. The proportion of the cultures that were positive of significant growth, the proportion of these positive isolates that were Streptococcus spp. and varied sensitivity pattern obtained underpinned the importance to advocate for culture isolates and susceptibility pattern guided treatment. These will not only an efficient approach to management of acute tonsillitis, but also a strong approach towards effective implementation of antibiotic stewardship.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34635755 PMCID: PMC8505406 DOI: 10.1038/s41598-021-99570-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Sociodemographic characteristics of the subjects.
| Variables | n | % |
|---|---|---|
| Male | 91 | 52.9 |
| Female | 81 | 47.1 |
| Mean | 3.8 years | |
| Median | 2 years | |
| Median | 4 days | |
| Yes | 124 | 72.1% |
| No | 48 | 27.9% |
| Yes | 24 | 14% |
| No | 148 | 86% |
| Mother | 151 | 87.60% |
| Father | 11 | 6.20% |
| Grandmother | 4 | 2.30% |
| Aunt | 2 | 1.20% |
| Others | 5 | 2.70% |
| None | 0 | 0% |
| Primary | 2 | 1.30% |
| Secondary | 26 | 17.20% |
| Tertiary | 123 | 81.50% |
| Civil servant | 45 | 31.30% |
| Business | 25 | 17.40% |
| Housewife/unemployed | 23 | 16% |
| Teacher | 19 | 13.20% |
| Nurse | 7 | 4.80% |
| Petty trader | 4 | 2.80% |
| Others | 21 | 14.50% |
The common medication taken before presentation and the presenting symptoms of the subjects.
| Pre-medications | n = 132 | % | Presenting symptoms | n = 172 | % |
|---|---|---|---|---|---|
| Amoxicilli/Ampicillin | 21 | 15.90% | Fever | 127 | 73.80% |
| Augumentin/Co-amoxiclav | 26 | 19.70% | Weakness | 7 | 4.10% |
| Azithromycin | 3 | 2.30% | |||
| Cefexine | 2 | 1.50% | Cough | 74 | 43% |
| Ceftriaxone | 2 | 1.50% | Catarrh | 45 | 26.20% |
| Cefuroxine | 4 | 3% | Ear Pain | 12 | 7% |
| Ciprofloxacin | 1 | 0.8 | Ear discharge | 12 | 7% |
| Cotrimoxazole/Septrin | 4 | 3% | Noisy breathing | 11 | 6.40% |
| Erythromycin | 5 | 3.90% | Sore throat | 9 | 5.20% |
| Metronidazole | 4 | 3% | Mouth breathing | 4 | 2.30% |
| Orelox/Cefpodoxine | 7 | 5.30% | Difficult breathing | 3 | 1.70% |
| ACTs | 41 | 31.10% | Vomiting | 35 | 20.30% |
| Artemisinin Monotherapy | 10 | 7.60% | Throat pain | 27 | 15.70% |
| Camoquine | 3 | 2.30% | Loose stool | 17 | 9.90% |
| Chloroquine | 1 | 0.00% | Loss of appetite | 14 | 8.10% |
| Abdominal pain | 8 | 4.70% | |||
| Salivation | 3 | 1.70% | |||
| Mouth dour | 1 | 0.60% | |||
| Ibuprofen | 19 | 14.40% | Convulsion | 6 | 3.50% |
| Paracetamol | 34 | 25.80% | Headache | 5 | 2.90% |
| Excessive cry | 1 | 0.60% | |||
| Cough syrup | 18 | 13.60% | Pains | 10 | 5.80% |
| Vitamin C | 6 | 4.50% | Rash | 5 | 2.90% |
| Astymin | 3 | 2.30% | Swelling | 2 | 1.20% |
| Multivite | 1 | 0.80% | Eye discharge | 1 | 0.60% |
Figure 1The microorganism isolates from the swab culture.
The Antibiogram susceptibility and resistant pattern of the microbiota isolates.
| Isolates | Sensitivity pattern | Imipenem | Levofloxacin | Ceftriaxone | Azithromycin | Amoxicillin-Clavulanic | Cefexine | Ampicillin |
|---|---|---|---|---|---|---|---|---|
| Sensitive | 9 | 11 | 7 | 6 | 8 | 8 | 4 | |
| Resistant | 2 | 0 | 4 | 5 | 3 | 3 | 7 | |
| Sensitive | 13 | 11 | 13 | 9 | 5 | 4 | 2 | |
| Resistant | 0 | 2 | 0 | 4 | 8 | 9 | 11 | |
| Sensitive | 10 | 7 | 3 | 5 | 2 | 2 | 0 | |
| Resistant | 0 | 3 | 7 | 5 | 8 | 8 | 10 | |
| Sensitive | 5 | 3 | 3 | 3 | 0 | 0 | 0 | |
| Resistant | 0 | 2 | 2 | 2 | 5 | 5 | 5 | |
| Sensitive | 5 | 4 | 3 | 1 | 2 | 2 | 1 | |
| Resistant | 0 | 1 | 2 | 4 | 3 | 3 | 4 | |
| Sensitive | 2 | 0 | 2 | 2 | 2 | 0 | 0 | |
| Resistant | 0 | 2 | 0 | 0 | 0 | 2 | 2 | |
| Sensitive | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Resistant | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Summed sensitivity | 45 (95.7%) | 37 (78.7%) | 32 (68.1%) | 27 (57.4%) | 20 (42.6%) | 17 (36.3%) | 8 (17%) | |
| Summed resistant | 2 | 10 | 15 | 20 | 27 | 30 | 39 |
Comparative analysis of the isolates between the 1st episodes and those with previous episodes.
| Episodes of tonsillitis | ||||
|---|---|---|---|---|
| First episode | Had previous episode(s) | |||
| Positive bacterial isolate(s) | 44 (29.7%) | 3 (12.5%) | 3.087 | 0.079 |
| No bacterial isolate(s) | 104 (70.3%) | 21 (87.5%) | ||